8DI2 | pdb_00008di2

Site 2 insulin receptor binding peptide IM459N21


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-1H COSY20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide95% H2O/5% D2O100 mM7.41 atm298Bruker AVANCE III 600
22D 1H-1H TOCSY20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide95% H2O/5% D2O100 mM7.41 atm298Bruker AVANCE III 600
32D 1H-1H NOESY20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide95% H2O/5% D2O100 mM7.41 atm298Bruker AVANCE III 600
42D 1H-1H NOESY20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide95% H2O/5% D2O100 mM7.41 atm298Bruker AVANCE III 600
52D 1H-13C HSQC aliphatic20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide95% H2O/5% D2O100 mM7.41 atm298Bruker AVANCE III 600
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE III600
NMR Refinement
MethodDetailsSoftware
molecular dynamicsGROMACS
NMR Ensemble Information
Conformer Selection Criteriaall calculated structures submitted
Conformers Calculated Total Number16
Conformers Submitted Total Number16
Representative Model1 (fewest violations)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1refinementGROMACS5.0.7Mark Abraham, Berk Hess, David van der Spoel, and Erik Lindahl
2structure calculationGROMACS5.0.7Mark Abraham, Berk Hess, David van der Spoel, and Erik Lindahl
3chemical shift assignmentCcpNmr Analysis2CCPN
4peak pickingCcpNmr Analysis2CCPN